• Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology

  NCT05354882

  Unknown statusInterventionalNot ApplicableUpdated May 9, 2023
• CAP'Onco : Psychological and Social Consultation of Professional Accompaniment in Oncology

  NCT03302767

  CompletedInterventionalNot ApplicableUpdated May 4, 2021
• Peer Support Program in Cancer Patients Elkar Laguntza

  NCT05077371

  Unknown statusInterventionalNot ApplicableUpdated May 31, 2023
• Physical Activity Experiment on Male Prostate Cancer Patients

  NCT03866785

  CompletedInterventionalNot ApplicableUpdated Feb 8, 2023
• Supportive Care Needs of Former Child, AYA Cancer Patients, and of Their Parents: Evaluation During Long-term Follow-up

  NCT04711733

  CompletedObservationalUpdated Mar 5, 2025
• Medico-economic Evaluation of the ONCORAL Program for Ambulatory Patients Under Oral Anticancer Drugs Versus Usual Care

  NCT03660670

  Unknown statusInterventionalNot ApplicableUpdated Dec 12, 2023

ClinicalTrials.gov ID

NCT06817655

Lead Sponsor

Hospices Civils de LyonOTHER

Overall Status

Not yet recruiting

Study Type

Interventional

Phase

Not Applicable

Enrollment

720Estimated

Last Update Posted

Feb 10, 2025Actual

Start Date

Mar 15, 2025Estimated

Primary Completion Date

Jun 15, 2027Estimated

Completion Date

Jun 15, 2027Estimated

Official Title

Implementation and Evaluation of Peer Support in Oncology in France : a Multisite Participatory Action Research - Adaptation and Transfer in France of the Quebec PAROLE ONCO Research Program

Brief Summary

Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach.

The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on:

1. Evaluating clinical and psychosocial parameters
2. Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.

Detailed Description

Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach.

The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on:

1. Evaluating clinical and psychosocial parameters
2. Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.

• Cancer

• PaRole OncO France : Individual peer support

Ages Eligible for Study

Child (0-17)Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• Patient participants :

  • Patients with newly diagnosed or recurrent cancer (urological, digestive, mammary, pulmonary, ORL, peritoneal carcinosis, melanoma, oncohaematology)
  • French-speaking patients

• Patients adivsors :

  • Patient advisors will be past cancer patients not currently undergoing treatment for their cancer, and considered without evidence of disease
  • French-speaking patients

Exclusion Criteria:

• Patients participants :

  • Not followed in one of the participating units
  • Persons deprived of their liberty by judicial or administrative decision
  • Persons not affiliated to a social security scheme or beneficiaries of a similar scheme

• Patient advisors :

  • Recurrence of the disease
  • Currently undergoing treatment for active cancer

Primary Purpose

Supportive Care

Allocation

N/A

Interventional Model

Single Group Assignment

Masking

None (Open Label)

Lead Sponsor

Hospices Civils de LyonOTHER

sebastien.couraud@chu-lyon.fr